Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,835 USD | -1,34% | +0,27% | -41,19% |
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 34,98 mln. 32,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -17 mln. -15,76 mln. | Nettowinst (verlies) 2022 | -17 mln. -15,76 mln. | EV/omzet 2021 | - |
Nettoliquiditeiten 2021 | 9,36 mln. 8,68 mln. | Nettoliquiditeiten 2022 | 13,25 mln. 12,28 mln. | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-3,69
x | K/w-verhouding 2022 |
-1,65
x | Werknemers | 15 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 51,16% |
Recentste transcriptie over Akari Therapeutics, Plc
1 dag | -1,34% | ||
1 week | +0,27% | ||
Lopende maand | -21,91% | ||
1 maand | -17,34% | ||
3 maanden | -38,83% | ||
6 maanden | -55,02% | ||
Lopend jaar | -41,19% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Rachelle Jacques
CEO | Chief Executive Officer | 53 | 28-03-22 |
Founder | 79 | 01-09-15 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 19-07-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 01-06-16 |
Founder | 79 | 01-09-15 | |
Director/Board Member | 61 | 05-07-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 1,835 | -1,34% | 6 883 |
27-03-24 | 1,86 | -1,33% | 34 771 |
26-03-24 | 1,885 | -0,78% | 13 901 |
25-03-24 | 1,9 | +4,97% | 2 448 |
22-03-24 | 1,81 | -1,09% | 59 394 |
uitgestelde koers Nasdaq, 28 maart 2024 om 17:17 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-41,19% | 12,28 mln. | |
+2,86% | 108 mld. | |
+9,93% | 104 mld. | |
+6,58% | 23,66 mld. | |
-12,44% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,36% | 18,2 mld. | |
-13,21% | 16,19 mld. | |
+4,64% | 13,72 mld. | |
+34,69% | 12,22 mld. |